Navepegritide
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Navepegritide, covering 2026-02-18 to 2026-04-21. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Trial to Evaluate Efficacy and Safety of Navepegritide in Adolescents (12 - 18 Years of Age) With Achondroplasia. [Phase 2]